Compounds and compositions as protein kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 251/48 (2006.01) A61K 31/505 (2006.01) A61K 31/506 (2006.01) A61K 31/53 (2006.01) A61P 35/00 (2006.01) C07D 239/02 (2006.01) C07D 403/00 (2006.01)

Patent

CA 2539339

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, EGF-R, c-erbB2 kinase (HER-2), CHK2, FGFR3, p70S6K, PKC, PDGF-R, p38, TGF.beta. , KDR, c-Kit, b-RAF, c-RAF, FLT1 and/or FLT4 kinases.

L'invention porte sur une nouvelle classe de composés et sur des préparations pharmaceutiques les contenant, et sur leurs méthodes d'utilisation pour traiter ou prévenir des maladies ou troubles associés à une activité anormale ou déréglée de kinases, et en particulier de maladies ou troubles liés à une activité anormale des kinases, Abl, BCR-Abl, EGF-R, c-erbB2 (HER-2), CHK2, FGFR3, p70S6K, PKC, PDGF-R, p38, TGF?, KDR, c-Kit, b-RAF, c-RAF, FLT1 et/ou FLT4.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compounds and compositions as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and compositions as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1915707

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.